126 – Using technology and data to change how pharma and physicians do drug monitoring; David Gahan, RxMx
David Gahan is Chief Commercial Officer of RxMx. In this role, he manages sales, marketing and product development for RxMx across their global markets.
David was previously the founding CEO at RxMx for four years, and he has a wealth of pharmaceutical industry experience. David was previously responsible for developing brand plans for international adaptation and for driving the introduction and success of blockbuster drugs and therapies.
RxMx is a healthcare company with exceptional technology solutions and longstanding industry experience. RxMx was founded by doctors who refused to accept “business as usual” when prescribing new specialty medicines. The company empowers doctors and nurses to safely administer specialty medicines without increasing their burden, so they can focus on patient care.
In this episode, David helps us understand how RxMx does the heavy lifting in pharma using Intersystems to help healthcare practitioners focus more on understanding and achieving the best results for their patients.
Are you curious about the entire management process of innovative treatments and medications? Then tune into this episode where we get a better understanding on how medical specialists can improve patient drug monitoring. If you are solving for an innovative pharmaceutical solution, learn how to scale while developing products and get advice from an expert on how to launch your ideas.
Check out the episode and full show notes here.
To see the latest information, news, events and jobs on offer at RxMx, visit their Talking HealthTech Directory here.
Loving the show? Leave us a review, and share it with some friends, become a THT+ Member for early release, ad free and bonus episodes of the podcast, access to our online community forum, and free tickets to our quarterly summits. For more information visit here.
